New app and coach aim to close diabetes tech gap for black children
NCT ID NCT06074458
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a smartphone app called Glucosano, combined with help from a community health worker, can make it easier for Black children and young adults with type 1 diabetes to use advanced diabetes technologies like automated insulin delivery systems. The goal is to reduce racial disparities in technology use. Sixty participants will try the app and work with a health coach to see if this approach is accepted and helpful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Glucosano diabetes dashboard app and community health worker coaching
What this could lead to
If successful, this approach could help reduce racial disparities in access to diabetes technology, improving blood sugar control and quality of life for Black children and young adults with type 1 diabetes.
What could go wrong
This is a small, early-stage study (60 participants) focused on feasibility and acceptance, not on clinical outcomes. The intervention may not be widely adopted or may not lead to lasting changes in technology use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States